Gastrointestinal (GI): NSAIDs that block COX-1 activity have correlations with GI problems because of the inhibition of your synthesis of gastroprotective agents such as PGE2 as well as other prostaglandins. This inhibition results in lessened mucin production by gastric epithelial cells, considerably less bicarbonate secretion, and fewer epithelial mobile turnover, https://nickq245mml6.blog2news.com/profile